A STUDY TO PROVIDE ACCESS TO TRABECTEDIN IN PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC SOFT TISSUE SARCOMA WHO HAVE PERSISTENT OR RECURRENT DISEASE AND WHO ARE NOT EXPECTED TO BENEFIT FROM CURRENTLY AVAILABLE STANDARD OF CARE TREATMENT: